Yale School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (3)

2024

  1. Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus

    Frontiers in Immunology, Vol. 15

2022

  1. The Combined Expression of the Nonstructural Protein NS1 and the N-Terminal Half of NS2 (NS21-180) by ChAdOx1 and MVA Confers Protection against Clinical Disease in Sheep upon Bluetongue Virus Challenge

    Journal of Virology, Vol. 96, Núm. 3

2020

  1. A protective bivalent vaccine against Rift Valley fever and bluetongue

    npj Vaccines, Vol. 5, Núm. 1